BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11986940)

  • 1. Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation.
    Cripe LD; Gelfanov VM; Smith EA; Spigel DR; Phillips CA; Gabig TG; Jung SH; Fyffe J; Hartman AD; Kneebone P; Mercola D; Burgess GS; Boswell HS
    Leukemia; 2002 May; 16(5):799-812. PubMed ID: 11986940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
    Lagadinou ED; Ziros PG; Tsopra OA; Dimas K; Kokkinou D; Thanopoulou E; Karakantza M; Pantazis P; Spyridonidis A; Zoumbos NC
    Leukemia; 2008 Oct; 22(10):1899-908. PubMed ID: 18650843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
    Adler V; Pincus MR
    Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus.
    Hurd C; Waldron RT; Rozengurt E
    Oncogene; 2002 Mar; 21(14):2154-60. PubMed ID: 11948398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
    Fan M; Goodwin ME; Birrer MJ; Chambers TC
    Cancer Res; 2001 Jun; 61(11):4450-8. PubMed ID: 11389075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
    Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
    Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun.
    Schepers H; Geugien M; van der Toorn M; Bryantsev AL; Kampinga HH; Eggen BJ; Vellenga E
    Exp Hematol; 2005 Jun; 33(6):660-70. PubMed ID: 15911090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
    Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
    Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells.
    Xu B; Shi P; Fombon IS; Zhang Y; Huang F; Wang W; Zhou S
    Blood Cells Mol Dis; 2011 Dec; 47(4):264-9. PubMed ID: 21911303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase.
    Villafania A; Anwar K; Amar S; Chie L; Way D; Chung DL; Adler V; Ronai Z; Brandt-Rauf PW; Yamaizumii Z; Kung HF; Pincus MR
    Ann Clin Lab Sci; 2000 Jan; 30(1):57-64. PubMed ID: 10678584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
    Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM
    Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase.
    Fuchs SY; Dolan L; Davis RJ; Ronai Z
    Oncogene; 1996 Oct; 13(7):1531-5. PubMed ID: 8875991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
    Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
    Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.